Acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subject must have a full understanding of the content, process and possible adverse reactions before the trial, and have voluntarily signed a written informed consent; 2. Subjects were able to communicate well with investigators and to complete the trial in accordance with protocol; 3. Aged >= 14 years (including boundary values, subjects under 18 years old required both guardian and informed consent); 4. Gender: male and female; 5. Patients with moderate (Grade II) acne Pillsbury 4-grade skin lesions, which mainly presented on the face; 6. Patients voluntarily participated in the clinical observation and signed an informed consent acne vulgaris. Willing to cooperate with follow-up observation. Good communication and understanding skills.
Exclusion criteria
Exclusion criteria: 1. Pillsbury's 4-step classification for mild (grade I) , moderate (Grade III) and severe (Grade IV) acne vulgaris; 2. Systemic treatment within 3 months (tretinoin and photodynamic therapy within 6 months); 3. The patients were treated with topical acne drugs or efficacy skin care products one week before they were enrolled in the study group; 4. The patients were complicated with other skin diseases which might affect the efficacy evaluation; 5. Related diseases of female patients treated with estrogen or estrogen-like hormone; 6. Patients with allergic history to the drugs and ingredients; 7. Patients with severe heart, brain, lung, liver and kidney function impairment; 8. Pregnant and lactating women; 9. Patients with a history of mental illness, recent history of alcohol abuse or drug abuse; 10. Patients who are unwilling to sign the informed consent form, and those who are unwilling to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of skin lesions;Global Acne Grading System quantitative indicators; | — |
Countries
China
Contacts
Shenzhen Luohu District Hospital of Traditional Chinese Medicine